about
Counselling for mental health and psychosocial problems in primary careEffectiveness and cost effectiveness of counselling in primary careCost-effectiveness of collaborative care for the treatment of depressive disorders in primary care: a systematic reviewVariations in the quality and costs of end-of-life care, preferences and palliative outcomes for cancer patients by place of death: the QUALYCARE study.Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses.Health costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients: a two-year prospective cohort study in anthroposophic outpatient settings.The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective.Trial-based economic evaluations in occupational health: principles, methods, and recommendationsShould NICE's advice be handled centrally or locally?Statistical methods for cost-effectiveness analyses that use data from cluster randomized trials: a systematic review and checklist for critical appraisal.Can choices between alternative hip prostheses be evidence based? a review of the economic evaluation literature.Cost-effectiveness of an exercise program during pregnancy to prevent gestational diabetes: results of an economic evaluation alongside a randomised controlled trial.Economic evaluations in bipolar disorder: a systematic review and critical appraisal.Cost-effectiveness of problem-solving treatment in comparison with usual care for primary care patients with mental health problems: a randomized trial.Trial-based clinical and economic analyses: the unhelpful quest for conformityThe clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical areaCosts of home versus inpatient treatment for fever and neutropenia: analysis of a multicenter randomized trial.Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting.Cost-utility analysis of case management for frail older people: effects of a randomised controlled trialCost-effectiveness of a disease management program for major depression in elderly primary care patients.Low back pain in general practice: cost-effectiveness of a minimal psychosocial intervention versus usual careThe Cost-Effectiveness of Two Forms of Case Management Compared to a Control Group for Persons with Dementia and Their Informal Caregivers from a Societal Perspective.Median-Based Incremental Cost-Effectiveness Ratio (ICER)The Cost Implications of Less Tight Versus Tight Control of Hypertension in Pregnancy (CHIPS Trial).Internet-Based Cognitive Behavioral Therapy for Insomnia: A Health Economic EvaluationCost effectiveness of a manual based coping strategy programme in promoting the mental health of family carers of people with dementia (the START (STrAtegies for RelaTives) study): a pragmatic randomised controlled trial.Cost effectiveness of medication adherence-enhancing interventions: a systematic review of trial-based economic evaluations.Barriers to the conduct of randomised clinical trials within all disease areas.Reporting and Analysis of Trial-Based Cost-Effectiveness Evaluations in Obstetrics and Gynaecology.A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder.Cost-effectiveness of a combined physical exercise and psychosocial training intervention for children with cancer: Results from the quality of life in motion study.Mud-Bath Therapy in Addition to Usual Care in Bilateral Knee Osteoarthritis: An Economic Evaluation Alongside a Randomized Controlled Trial.Hickman catheter and implantable port devices for the delivery of chemotherapy: a phase II randomised controlled trial and economic evaluation.Cost-effectiveness of cognitive-behavioral therapy for depression: current evidence and future research priorities.Four-Year Cost-effectiveness of Cognitive Behavior Therapy for Preventing First-episode Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.Economic evaluation of factorial randomised controlled trials: challenges, methods and recommendations.Nurse led care.Incremental cost-effectiveness analysis of a multidisciplinary renal education program for patients with chronic renal disease.Pharmacoeconomic aspects of memantine (Ebixa) in the treatment of Alzheimer's disease.Large-scale screening and subsequent effects of migraine treatment on the work floor in the Netherlands.
P2860
Q24234536-7089926B-D98D-424F-BB56-09BE959FE8A9Q24245061-CE2A700F-484D-4D9F-B731-ABC0771FFEFFQ27024741-7D21FD0F-4D12-4899-8F34-ECD2DF86C630Q30495966-32F312AF-DC47-4FE0-8AC7-98A9F5A746F5Q30801243-D922EE6A-8228-456F-9C18-DDCCA2FECAB6Q33629358-81C8E202-29E2-4763-83D4-052E696B66C6Q33697820-9EF9D9D8-A316-47CC-BF66-4EED35FE425FQ33718157-06A07A4D-4539-4E8F-999F-94DB49372B98Q33804444-039D0B77-5D1B-49F7-B37E-E0FA5381387DQ33910824-C42EE502-0352-436A-A58A-D28BD2AB1360Q34321543-2A3440A7-A229-45D2-B6A5-14472EF23EC7Q34326866-E1E8AAD2-7001-4113-8114-0F6B3D5A638EQ34424079-9827B2F3-6056-4CC4-947B-0C95662B1483Q34439498-5EE6972B-385E-4352-9EE1-04C7FBC41CACQ34521062-E38AE4A2-D685-4450-81D0-903EA5E858D3Q35274635-41DC8F4E-5A4C-41DF-B0FB-73B729A7A7E0Q35532487-6B7841B7-C152-4BEF-8E9E-2BE1A35DA744Q35590950-2087C385-60DA-4F9F-8F1B-605B82C6E2EDQ35666139-062F1EA1-12CF-414A-9052-0BFBC3854012Q35696121-207D5F78-6377-404B-B540-042A7D64D761Q36128864-E155A852-9FA9-49A5-905A-FACD73572190Q36140041-1C34213F-47C1-40D1-96AE-421209595FD0Q36623869-4682CB0A-C822-4A81-A324-C51BE989AE2EQ37224779-9EB99098-D4CF-4377-9AC6-678A9BBFF02EQ37251033-4FEC9133-C61D-4190-93CE-8A67D3B67DF5Q37254686-2B60FA82-002C-4B17-BB92-041AE982483FQ38162167-5BC0C95B-244C-413F-A1C4-FB0A66BFDF06Q38369293-A9C6D39D-2466-49FE-A0DC-09B152BB7543Q38694952-1A89E440-15D9-4CF7-B4CC-9928358A09ECQ38779921-095A053A-EC89-4ED2-BEA9-23FD52BD32F8Q39303542-496A1B3B-1438-44E1-AD73-1A078EC4A40EQ39306140-6F772680-EBC5-4275-A6CB-2CA914C9AEFFQ39840099-51557A81-06E6-425A-BE51-7F209B619737Q40630175-34B01C60-DBE1-4429-B376-BE6B8E95AA0BQ40699542-102F0D7A-BEAB-4AF0-B2B4-839821218CE8Q41990253-4B76FBE7-D112-4C33-B8FF-57ABBB278992Q43001146-95544E03-A591-4632-ADB2-8D6A7CDD6671Q43185876-C1BDAAC4-F100-46FA-BEBC-1A5C3D52CBB9Q43266420-B75533BF-E24C-4B9E-BC4C-8E69BCB71845Q46142932-AF2B776F-FA07-4487-8411-2017A6444FBD
P2860
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Economic evaluation and clinical trials: size matters.
@en
Economic evaluation and clinical trials: size matters.
@nl
type
label
Economic evaluation and clinical trials: size matters.
@en
Economic evaluation and clinical trials: size matters.
@nl
prefLabel
Economic evaluation and clinical trials: size matters.
@en
Economic evaluation and clinical trials: size matters.
@nl
P2860
P1433
P1476
Economic evaluation and clinical trials: size matters.
@en
P2093
P2860
P304
P356
10.1136/BMJ.321.7273.1362
P407
P577
2000-12-01T00:00:00Z